MMF Rewind | Building Better Clinical Trials: Study Start-Up, Patients, and Global Data

<p>This week, we&#39;re revisiting a previous conversation with Megan Kamm, Senior Vice President of Client Delivery, and Josh Schroeder, Vice President of Site &amp; Field Operations, to discuss how strong planning, site partnerships, and cross-functional collaboration drive successful trial execution. From feasibility and study startup to patient-centered decision-making, biometrics strategy, and global expansion, they share insights into the operational challenges—and opportunities—behind bringing innovative therapies to patients faster.  </p><p> </p><p><strong>01:18 Megan Kamm and Josh Schroeder discuss how their expanded leadership roles have created new opportunities to collaborate across functions and support trial delivery. </strong></p><p><strong>03:12 The conversation explores the early decisions that shape trial success, from feasibility planning to selecting the right sites and regions.  </strong></p><p><strong>04:22 Megan explains how site engagement and thoughtful study design help reduce burden and support successful trial execution. </strong></p><p><strong>05:28 Josh and Megan share how project teams, CRAs, and other functions work together to keep studies running smoothly. </strong></p><p><strong>06:15 The discussion highlights common challenges during study startup and how proactive planning can reduce delays and enrollment risks. </strong></p><p><strong>10:23 Josh and Megan provide examples of how strong collaboration helped accelerate enrollment and deliver data more efficiently. </strong></p><p><strong>12:32 Megan discusses how biometrics teams contribute from protocol development through data analysis, helping guide study strategy.  </strong></p><p><strong>13:32 Josh explains how endpoint priorities and statistical planning influence monitoring strategies throughout a trial. </strong></p><p><strong>14:43 The conversation turns to leadership, focusing on training, alignment, and consistent decision-making across global teams. </strong></p><p><strong>16:02 Megan and Josh reflect on what sets CTI apart, highlighting a culture centered on patients and collaboration.  </strong></p><p><strong>18:26 The discussion looks at the future of clinical research, including advances in technology, AI, and trial operations. </strong></p><p><strong>20:32 Josh shares insights into CTI’s growth in China and the operational considerations that come with expanding into the region.</strong></p><p><br></p>